Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 4297206, 7 pages
https://doi.org/10.1155/2017/4297206
Research Article

Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis

1Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy, Marinescu str. No.23, Cluj-Napoca, Romania
24th Department of Internal Medicine, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
33rd Department of Internal Medicine, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

Correspondence should be addressed to Raluca Maria Pop; moc.oohay@golrap_acular

Received 9 June 2017; Accepted 9 July 2017; Published 9 August 2017

Academic Editor: Giuseppe Valacchi

Copyright © 2017 Ioana Corina Bocsan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bellentani, “The epidemiology of non-alcoholic fatty liver disease,” Liver International, vol. 37, Supplement 1, pp. 81–84, 2017. View at Publisher · View at Google Scholar
  2. G. Bedogni, L. Miglioli, F. Masutti et al., “Incidence and natural course of fatty liver in the general population: the Dionysos study,” Hepatology, vol. 46, no. 5, pp. 1387–1391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Zelber-Sagi, R. Lotan, A. Shlomai et al., “Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up,” Journal of Hepatology, vol. 56, pp. 1145–1151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Romero-Gómez, S. Zelber-Sagi, and M. Trenell, “Treatment of NAFLD with diet, physical activity and exercise,” Journal of Hepatology, 2017. View at Publisher · View at Google Scholar
  5. M. L. Fernandez and K. L. West, “Mechanisms by which dietary fatty acids modulate plasma lipids,” The Journal of Nutrition, vol. 135, no. 9, pp. 2075–2078, 2005. View at Google Scholar
  6. P. W. Siri-Tarino, Q. Sun, F. B. Hu, and R. M. Krauss, “Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients,” Current Atherosclerosis Reports, vol. 12, no. 6, pp. 384–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. P. Day and O. F. James, “Steatohepatitis: a tale of two hits?” Gastroenterology, vol. 114, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Rolo, J. S. Teodoro, and C. M. Palmeira, “Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis,” Free Radical Biology and Medicine, vol. 52, no. 1, pp. 59–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Peter and N. Tommy, “Non-alcoholic fatty liver disease—a chronic disease of the 21st century,” Journal of Biomedical Research, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  10. H. Tilg, “The role of cytokines in non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 179–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Hammerich and F. Tacke, “Interleukins in chronic liver disease: lessons learned from experimental mouse models,” Clinical and Experimental Gastroenterology, vol. 7, pp. 297–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Paredes-Turrubiarte, A. González-Chávez, R. Pérez-Tamayo et al., “Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients,” Clinical and Experimental Medicine, vol. 16, no. 2, pp. 193–202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Uysal, F. Armutcu, T. Aydogan, K. Akin, M. Ikizek, and M. R. Yigitoglu, “Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis,” Clinical Biochemistry, vol. 44, no. 17-18, pp. 1375–1379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Stojsavljević, M. Gomerčić Palčić, L. Virović Jukić, L. Smirčić Duvnjak, and M. Duvnjak, “Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 48, pp. 18070–18091, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kumar, S. Prakash, S. Chhabra et al., “Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease,” The Indian Journal of Medical Research, vol. 136, pp. 229–236, 2012. View at Google Scholar
  16. R. B. Merriman, B. E. Aouizerat, and N. M. Bass, “Genetic influences in nonalcoholic fatty liver disease,” Journal of Clinical Gastroenterology, vol. 40, Supplement 1, pp. S30–S33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ishii, T. Matsuse, S. Teramoto et al., “Neither IL-1b, IL-1 receptor antagonist, nor TNF-a polymorphisms are associated with susceptibility to COPD,” Respiratory Medicine, vol. 94, pp. 847–851, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. O. P. Kristiansen, R. L. Nolsøe, L. Larsen et al., “Association of a functional 17b-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females,” Human Molecular Genetics, vol. 12, no. 10, pp. 1101–1110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Guo, N. Wang, Y. M. Wang, and J. H. Zhang, “Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of North China,” World Journal of Gastroenterology, vol. 11, no. 6, pp. 858–862, 2005. View at Publisher · View at Google Scholar
  20. S. K. Das and V. Balakrishnan, “Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease,” Indian Journal of Clinical Biochemistry, vol. 26, no. 2, pp. 202–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. W. E. Zahran, K. A. Salah El-Dien, P. G. Kamel, and A. S. El-Sawaby, “Efficacy of tumor necrosis factor and interleukin-10 analysis in the follow-up of nonalcoholic fatty liver disease progression,” Indian Journal of Clinical Biochemistry, vol. 28, no. 2, pp. 141–146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Straczkowski, I. Kowalska, A. Nikolajuk, A. Krukowska, and M. Gorska, “Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals,” Diabetes Care, vol. 28, no. 8, pp. 2036-2037, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. Jorge, J. M. Andrade, A. F. Paraíso et al., “Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity,” Obesity Research & Clinical Practice, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Uchil, D. Pipalia, M. Chawla et al., “Non-alcoholic fatty liver disease (NAFLD)—the hepatic component of metabolic syndrome,” The Journal of the Association of Physicians of India, vol. 57, pp. 201–204, 2009. View at Google Scholar
  25. J. Trifunović, L. Miller, Ž. Debeljak, and V. Horvat, “Pathologic patterns of interleukin 10 expression—a review,” Biochemical Medicine, vol. 25, no. 1, pp. 36–48, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Bennermo, C. Held, S. Stemme et al., “Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?” Clinical Chemistry, vol. 50, pp. 2136–2140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. F. Terry, V. Loukaci, and F. R. Green, “Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation,” The Journal of Biological Chemistry, vol. 275, no. 24, pp. 18138–18144, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Popko, E. Gorska, and U. Demkow, “Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance,” European Journal of Medical Research, vol. 15, Supplement 2, pp. 123–127, 2010. View at Google Scholar
  29. A. G. Wilson, J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff, “Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, pp. 3195–3199, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. S. C. Sookoian, C. González, and C. J. Pirola, “Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome,” Obesity Research, vol. 13, no. 12, pp. 2122–2131, 2005. View at Publisher · View at Google Scholar
  31. M. Cengiz, D. G. Yasar, M. A. Ergun, G. Akyol, and S. Ozenirler, “The role of interleukin-6 and interleukin-8 gene polymorphisms in non-alcoholic steatohepatitis,” Hepatitis Monthly, vol. 14, no. 12, article e24635, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Tosic Dragovic, J. Popovic, P. Djuric et al., “Relative risk for cardiovascular morbidity in hemodialysis patients regarding gene polymorphism for IL-10, IL-6, and TNF,” Canadian Journal of Physiology and Pharmacology, vol. 94, no. 10, pp. 1106–1109, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Ma, G. Sun, W. Wang et al., “Association between interleukin-6 -572 C>G and -174 G>C polymorphisms and hypertension: a meta-analysis of case-control studies,” Medicine (Baltimore), vol. 95, no. 2, article e2416, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Meenagh, F. Williams, O. A. Ross et al., “Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America,” Human Immunology, vol. 63, pp. 1055–1061, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. P. Reynard, D. Turner, and C. V. Navarrete, “Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK,” European Journal of Immunogenetics, vol. 27, no. 4, pp. 241–249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. B. J. Swiątek, “Is interleukin-10 gene polymorphism a predictive marker in HCV infection?” Cytokine & Growth Factor Reviews, vol. 23, no. 1-2, pp. 47–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. W. Hu, H. B. Luo, Y. M. Xu et al., “Tumor necrosis factor—alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases,” Acta Gastroenterologica Belgica, vol. 72, no. 2, pp. 215–221, 2009. View at Google Scholar